ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $416,392 | -61.3% | 11,680 | -49.9% | 0.10% | -60.9% |
Q2 2023 | $1,074,829 | +23.2% | 23,300 | +7.1% | 0.27% | +26.1% |
Q1 2023 | $872,175 | -13.4% | 21,750 | 0.0% | 0.21% | -13.5% |
Q4 2022 | $1,007,678 | +6.5% | 21,750 | -4.8% | 0.24% | +8.4% |
Q3 2022 | $946,000 | +1.9% | 22,840 | +46.9% | 0.22% | +3.2% |
Q2 2022 | $928,000 | -17.8% | 15,550 | 0.0% | 0.22% | -46.2% |
Q1 2022 | $1,129,000 | -13.7% | 15,550 | 0.0% | 0.40% | +45.7% |
Q4 2021 | $1,308,000 | +20.0% | 15,550 | +28.6% | 0.28% | -15.0% |
Q3 2021 | $1,090,000 | +62.0% | 12,090 | +71.1% | 0.33% | +69.4% |
Q2 2021 | $673,000 | +2.6% | 7,065 | +22.5% | 0.19% | -13.5% |
Q1 2021 | $656,000 | +42.9% | 5,765 | +73.6% | 0.22% | +50.7% |
Q4 2020 | $459,000 | -51.2% | 3,320 | -71.0% | 0.15% | -48.1% |
Q3 2020 | $941,000 | -27.2% | 11,450 | -30.7% | 0.28% | -22.3% |
Q2 2020 | $1,292,000 | +98.2% | 16,515 | +12.6% | 0.37% | +54.2% |
Q1 2020 | $652,000 | +4.2% | 14,665 | 0.0% | 0.24% | -4.0% |
Q4 2019 | $626,000 | +13.2% | 14,665 | +13.5% | 0.25% | +15.9% |
Q3 2019 | $553,000 | -16.0% | 12,925 | +24.7% | 0.21% | -23.3% |
Q2 2019 | $658,000 | -8.5% | 10,365 | 0.0% | 0.28% | -15.7% |
Q1 2019 | $719,000 | +126.1% | 10,365 | +41.7% | 0.33% | +105.6% |
Q4 2018 | $318,000 | -40.9% | 7,315 | +3.8% | 0.16% | -31.2% |
Q3 2018 | $538,000 | +20.6% | 7,045 | +21.5% | 0.23% | +11.4% |
Q2 2018 | $446,000 | – | 5,800 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |